Effects and Safety of Calcimimetics in End Stage Renal Disease Patients with Secondary Hyperparathyroidism: A Meta-Analysis
PLoS ONE2012Vol. 7(10), pp. e48070–e48070
Citations Over TimeTop 18% of 2012 papers
Abstract
Calcimimetic treatment effectively improved biochemical parameters of SHPT patients receiving dialysis without increasing all-cause mortality and all adverse events.
Related Papers
- → Mechanism of calcitriol regulating parathyroid cells in secondary hyperparathyroidism(2022)16 cited
- → Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients(2019)21 cited
- → The role of vitamin D deficiency in parathyroid hormone levels(2013)10 cited
- → Biological profile of secondary hyperparathyroidism in chronic renal failure(2022)
- → [MiR-301a-5p modulates parathyroid hormone secretion in secondary hyperparathyroidism possibly by regulating calcium-sensing receptor].(2023)